If these mechanisms can be further established, it opens for prophylactic treatment of pre-T1D with GLP-1 analogues, metformin or potassium channel blockers to possibly activate the dormant beta cells. The gene discussed is KCNA3; the disease is type 1 diabetes mellitus.